ONS/ONCC Chemotherapy
Immunotherapy
Certificate exam
1.
Question: What is the primary purpose of a chemotherapy consent form?
Answer: To ensure the patient understands the purpose, risks, benefits, and
alternatives of chemotherapy and provides informed consent before treatment.
2.
Question: Before administering chemotherapy, what must the nurse verify?
Answer: The chemotherapy order, patient identity (two identifiers), dose
calculations, BSA, route, drug compatibility, and timing.
3.
Question: What is the most accurate way to calculate chemotherapy dosage?
Answer: Using the patient’s Body Surface Area (BSA) in m², derived from height and
weight.
4.
Question: Which PPE is required for preparing and administering IV chemotherapy?
,Answer: Chemotherapy-tested gloves (double-gloved), disposable gown, and
face/eye protection if there’s a risk of splashing.
5.
Question: What type of tubing is used for vesicant chemotherapy drugs?
Answer: Non-polyvinyl chloride (non-PVC) tubing with a free-flowing IV line and Y-
site connection for safety.
6.
Question: What is a vesicant drug?
Answer: A drug that can cause tissue necrosis and blistering if it extravasates.
7.
Question: What is the immediate action if extravasation is suspected?
Answer: Stop the infusion, leave the needle in place, aspirate residual drug, and
notify the provider.
8.
Question: What should the nurse do after chemotherapy administration?
Answer: Flush the line with a compatible solution, dispose of PPE and materials in a
cytotoxic waste container, and document the administration and patient response.
9.
Question: What is the recommended duration for nurses to avoid handling
chemotherapy drugs if pregnant?
Answer: Pregnant or breastfeeding staff should avoid handling chemotherapy or
hazardous drugs entirely.
, 10.
Question: What is the appropriate management for hypersensitivity reactions during
immunotherapy?
Answer: Stop the infusion immediately, assess airway and vital signs, administer
emergency medications (e.g., epinephrine, corticosteroids), and notify the provider.
11.
Question: What type of tubing should be used for taxane chemotherapy agents (e.g.,
paclitaxel)?
Answer: Non-PVC tubing and a 0.22-micron inline filter.
12.
Question: What is the purpose of a biologic safety cabinet (BSC)?
Answer: To protect the nurse, the drug, and the environment from hazardous drug
exposure during preparation.
13.
Question: What is a common immune-related adverse effect of checkpoint inhibitors
(e.g., pembrolizumab)?
Answer: Autoimmune reactions such as pneumonitis, colitis, hepatitis, or
endocrinopathies.
14.
Question: What is the antidote for extravasation caused by anthracyclines (e.g.,
doxorubicin)?
Answer: Dexrazoxane (Totect).
Immunotherapy
Certificate exam
1.
Question: What is the primary purpose of a chemotherapy consent form?
Answer: To ensure the patient understands the purpose, risks, benefits, and
alternatives of chemotherapy and provides informed consent before treatment.
2.
Question: Before administering chemotherapy, what must the nurse verify?
Answer: The chemotherapy order, patient identity (two identifiers), dose
calculations, BSA, route, drug compatibility, and timing.
3.
Question: What is the most accurate way to calculate chemotherapy dosage?
Answer: Using the patient’s Body Surface Area (BSA) in m², derived from height and
weight.
4.
Question: Which PPE is required for preparing and administering IV chemotherapy?
,Answer: Chemotherapy-tested gloves (double-gloved), disposable gown, and
face/eye protection if there’s a risk of splashing.
5.
Question: What type of tubing is used for vesicant chemotherapy drugs?
Answer: Non-polyvinyl chloride (non-PVC) tubing with a free-flowing IV line and Y-
site connection for safety.
6.
Question: What is a vesicant drug?
Answer: A drug that can cause tissue necrosis and blistering if it extravasates.
7.
Question: What is the immediate action if extravasation is suspected?
Answer: Stop the infusion, leave the needle in place, aspirate residual drug, and
notify the provider.
8.
Question: What should the nurse do after chemotherapy administration?
Answer: Flush the line with a compatible solution, dispose of PPE and materials in a
cytotoxic waste container, and document the administration and patient response.
9.
Question: What is the recommended duration for nurses to avoid handling
chemotherapy drugs if pregnant?
Answer: Pregnant or breastfeeding staff should avoid handling chemotherapy or
hazardous drugs entirely.
, 10.
Question: What is the appropriate management for hypersensitivity reactions during
immunotherapy?
Answer: Stop the infusion immediately, assess airway and vital signs, administer
emergency medications (e.g., epinephrine, corticosteroids), and notify the provider.
11.
Question: What type of tubing should be used for taxane chemotherapy agents (e.g.,
paclitaxel)?
Answer: Non-PVC tubing and a 0.22-micron inline filter.
12.
Question: What is the purpose of a biologic safety cabinet (BSC)?
Answer: To protect the nurse, the drug, and the environment from hazardous drug
exposure during preparation.
13.
Question: What is a common immune-related adverse effect of checkpoint inhibitors
(e.g., pembrolizumab)?
Answer: Autoimmune reactions such as pneumonitis, colitis, hepatitis, or
endocrinopathies.
14.
Question: What is the antidote for extravasation caused by anthracyclines (e.g.,
doxorubicin)?
Answer: Dexrazoxane (Totect).
